e:Med – Module II – Consortium Project: HER2Low – Mathematical Modelling of the Mechanism of Action of Therapeutic Antibodies Targeting Human Epidermal Growth Factor Receptor 2, Epidermal Growth Factor Receptor and Erb‑B2 Receptor Tyrosine Kinase 3 for Personalisation of Breast Cancer Therapy

✏️ Listing Description:

📁 Related Knowledgebase Resources

.

📁 Related Innovation Offers

.

📁 Related Funding and Finance Opportunities

.

Access Restricted

This knowledgebase resource is only fully available for users with Personal Access or Professional Access.

Already member? - Login Get instant access (19,99 € / month) See your options Book a Meeting